| Could mass testing reduce the need for social distancing and other restrictions during the SARS-CoV-2 pandemic? A mathematical modeling analysis | Oral abstract session with live Q&A | Non-pharmaceutical prevention |
| COVID-19 as a social disease: exploring prevention needs, impact and community responses to COVID-19 among ethnic minorities in Antwerp, Belgium | E-poster | Non-pharmaceutical prevention |
| COVID-19 impact among the minorities groups (Hijra and female sex workers) of Bangladesh and how to save them from the humanitarian perspective | E-poster | Non-pharmaceutical prevention |
| Covid-19 programmatic adaptations: using mobile application for continued access to HIV services among key populations in Namibia | E-poster | Non-pharmaceutical prevention |
| CRISPR-Cas13b can potently suppress replication of SARS-CoV-2 and mutant strains | Oral abstract session with live Q&A | Basic science |
| Detrimental health effects of changes in cannabis use during the first COVID-19 lockdown among daily cannabis users in France: results from a national survey | E-poster | Global access and policy |
| Distinct humoral trajectories associated with both HIV co-infection and COVID-19 survival in a hospitalized South African SARS-CoV-2 cohort | E-poster | no category |
| Dysregulation of B cell subpopulations and high antibody titers against herpesvirus in patients with COVID-19 admitted to the ICU | E-poster | Basic science |
| Early rollout of COVID-19 vaccines providing protection against infection rather than symptoms would prevent the most cases and deaths in King County, Washington, US: a modeling analysis | Oral abstract session with live Q&A | Vaccines |
| Effect of COVID-19 on risky behaviours of female sex workers in Ga South Municipal of Ghana and its wider implications: evidence from a qualitative study | E-poster | Non-pharmaceutical prevention |